$JANX Cashflow Statement | Understand Stock

$JANX

$17.26 +$0.57 (3.42%) Close

$JANX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Loss on disposal of assets
Stock-based compensation
Noncash interest – related parties
Accretion of discounts on investments, net
Increase in fair value of convertible promissory notes – related parties
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Other long-term assets
Accounts payable
Accrued expenses
Deferred revenue
Operating lease right-of-use assets and liabilities, net

Net cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment
Purchases of short-term investments
Maturities of short-term investments
Net cash used in investing activities
Cash flows from financing activities
Proceeds from issuance of convertible promissory notes
Proceeds from issuance of convertible preferred stock, net of issuance costs
Series Seed 2 Convertible Preferred Stock
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Proceeds from exercise of vested and unvested common stock options and employee stock purchase plan
Proceeds from initial public offering, net of issuance costs
Proceeds from exercise of common stock options and employee stock purchase plan
Proceeds from the issuance of common stock and pre-funded common stock warrants, net of issuance costs
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of year
Cash, cash equivalents and restricted cash - end of period
Supplemental disclosure of noncash investing and financing activities
Conversion of convertible preferred stock to common stock in connection with initial public offering, converted
Conversion of convertible promissory notes and accrued interest into shares of convertible preferred stock
Unpaid property and equipment
Unpaid issuance costs
Vesting of restricted common stock
Unrealized gain on available-for-sale securities, net
Operating lease liabilities arising from right-of-use assets

Comments